COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

OCCPR Webinar: Network Exploration Tool for Cancer Research

Finding novel interactions from OCCPR Webinar: Network Exploration invitationcomprehensive genomics and proteomics (mass spectrometry generated) is made significantly easier with the help of a visual, interactive guide. Researchers from the Mount Sinai Protogenomic Data Analysis Center (PGDAC) team within the Clinical Proteomics Tumor Analysis Consortium (CPTAC) program have developed a new three-dimensional tool to explore novel interactions in the context of a specific cancer type. Developed for the recent CPTAC kidney cancer study published in Cell, this Network Exploration Tool is now available for the scientific community to use.

Join Assistant Professor Zeynep Gumus, Ph.D., with Dr. Pei Wang’s group at the Ichan School of Medicine at Mount Sinai Thursday, April 9th at 2:00 p.m. to find out more about the Network Exploration Tool. This webinar will help participants explore this tool and how to utilize it. Registration is required Registrants are encouraged to preview the tool before the webinar (click here).

This webinar is brought to you by the Office of Cancer Clinical Proteomics Research (OCCPR). OCCPR aims to improve prevention, early detection, diagnosis, and treatment of cancer by enhancing the understanding of the molecular mechanisms of cancer, advancing proteome/proteogenome science and technology development through community resources (data and reagents), and acceleration the translation of molecular findings into the clinic.